<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04196400</url>
  </required_header>
  <id_info>
    <org_study_id>Hypospadias-101</org_study_id>
    <nct_id>NCT04196400</nct_id>
  </id_info>
  <brief_title>The Role of Local Long Acting Corticosteroid Injection in Hypospadias Surgery.</brief_title>
  <official_title>Prospective Comparative Trial to Assess the Role of Local Long Acting Steroid Injection After Hypospadias Surgery in Decreasing Complications and Preserving Better Cosmesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-operative tissue oedema is one of the main causes of failure of hypospadias repair.
      Severe oedema may disrupt the suture line, invite infection and result in repair failure.
      Thus, we suggested that local injection of corticosteroids in just below coronal sulcus into
      dartos and buck's fascia may limit this oedema thus improving the outcome of hypospadias
      repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective comparative trial : comparing the use of local steroids injection to
      reduce tissue edema after hypospadias and to preserve the final cosmesis after tissue repair.

      The patients will be divided into 2 groups(each group 20 patients): one group will be
      injected steroids just after hypospadias surgery while the other will not.

      The short and long term outcomes between both groups will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>comparative prospective clinical trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Failure rate</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of Tissue edema</measure>
    <time_frame>3 days, 5 days, 10 days, 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection Rate</measure>
    <time_frame>3 days, 5 days, 10 days, 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fistula rate</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Final cosmesis</measure>
    <time_frame>3 days, 5 days, 10 days, 2 weeks</time_frame>
    <description>The shape of the glans penis and surrounding tissue</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypospadias</condition>
  <arm_group>
    <arm_group_label>Steroid injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Steroid (betamethasone) 2 ml is injected subcutaneously after finishing the operation at the repair site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>steroid betamethasone</intervention_name>
    <description>The steroid is injected using insulin needle in the subcutaneous tissue after finishing the repair</description>
    <arm_group_label>Steroid injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypospadias Patient

          -  Recurrent Cases

          -  6 months or more

          -  Distal, and mid penile hypospadias

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cairo Univeristy Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>002</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2019</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed Abozamel</investigator_full_name>
    <investigator_title>Doctor Lecturer in Urology department</investigator_title>
  </responsible_party>
  <keyword>hypospadias, edema, failure, fistula, steroids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypospadias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Betamethasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

